Supplementary Table 3 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Response in tumor biomarker subgroups among participants with biliary tract cancer (cohort F)
Fields of Study & Subjects
Cholangiocarcinoma and Gallbladder Cancer Studies
Pancreatic and Hepatic Oncology Research
Gastric Cancer Management and Outcomes
Publication details
- Publication date
- 26 March 2026
- Language
- EN